Avak Kahvejian
About Avak Kahvejian
Venture capital investor (President, Flagship Labs) based in Cambridge, Massachusetts. Focus areas include Creative Venture, Clean Tech, Health Care. Invests at early stage venture, series a stage. Past investments include KSQ Therapeutics, Denali Therapeutics, Syros Pharmaceuticals.
Investment focus
Stages
Sectors
Creative VentureClean TechHealth CareResearch and DevelopmentRegenerative MedicineDrug DiscoveryWellnessWomen FoundedHealthcare InnovationStrategic PartnershipsLife ScienceEngineeringArtificial Intelligence (AI)ScienceVenture FundraisingBiotechnologyMedical DevicesDrug DevelopmentHispanic / Latinx FoundedClean Technology
Portfolio
No portfolio companies recorded yet; Avak Kahvejian reports 60 investments overall.